| Ticker Details |
United Therapeutics Corporation
United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients.
|
| IPO Date: |
June 17, 1999 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$20.38B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.70 | 1.39%
|
| Avg Daily Range (30 D): |
$3.85 | 0.81%
|
| Avg Daily Range (90 D): |
$5.03 | 1.08%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.6M |
| Avg Daily Volume (30 D): |
.24M |
| Avg Daily Volume (90 D): |
.33M |
| Trade Size |
| Avg Trade Size (Sh.): |
99 |
| Avg Trade Size (Sh.) (30 D): |
18 |
| Avg Trade Size (Sh.) (90 D): |
21 |
| Institutional Trades |
| Total Institutional Trades: |
14,398 |
| Avg Institutional Trade: |
$5.16M |
| Avg Institutional Trade (30 D): |
$24.01M |
| Avg Institutional Trade (90 D): |
$25.74M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$9.98M |
| Avg Closing Trade (30 D): |
$26.13M |
| Avg Closing Trade (90 D): |
$35.93M |
| Avg Closing Volume: |
59.04K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$27.68
|
$6.86
|
$7.18
|
|
Diluted EPS
|
$25.64
|
$6.41
|
$6.63
|
|
Revenue
|
$3.08B
|
$798.6M
|
$794.4M
|
|
Gross Profit
|
$2.74B
|
$711M
|
$701.9M
|
|
Net Income / Loss
|
$1.24B
|
$309.5M
|
$322.2M
|
|
Operating Income / Loss
|
$1.45B
|
$364.5M
|
$382.8M
|
|
Cost of Revenue
|
$339.1M
|
$87.6M
|
$92.5M
|
|
Net Cash Flow
|
$237.4M
|
$-306.8M
|
$202.7M
|
|
PE Ratio
|
18.46
|
|
|
|
|
|
